Literature DB >> 21606294

Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma.

Junichi Arita1, Kiyoshi Hasegawa, Michiro Takahashi, Shojiro Hata, Junichi Shindoh, Yasuhiko Sugawara, Norihiro Kokudo.   

Abstract

OBJECTIVE: Our aim was to accurately assess the correlation between findings of contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of hepatocellular carcinoma (HCC). SUBJECTS AND METHODS: We enrolled 239 consecutive patients who were undergoing surgery for HCC for this study. Because 33 extensively necrotic HCCs were excluded, a total of 374 histologically proven HCCs were detected in all resected specimens and were the study subjects (71 well-differentiated, 239 moderately differentiated, and 64 poorly differentiated HCCs). After a laparotomy and liver mobilization, contrast-enhanced intraoperative ultrasound in the harmonic mode was performed after a Sonazoid injection. The first minute was defined as the vascular phase, in which the vascularity of the 239 HCCs was assessed. After an approximately 15-minute delay, a thorough liver exploration was performed (Kupffer phase). Preoperative dynamic CT was routinely performed, and the findings were assessed for reference.
RESULTS: The proportion of hypervascular tumors during the vascular phase tended to be lower among well-differentiated than among moderately and poorly differentiated HCCs (66% vs 80%, p = 0.058). The proportion of hypoechoic tumors during the Kupffer phase was significantly lower among well-differentiated than among moderately and poorly differentiated HCCs (54% vs 92%, p < 0.0001). In dynamic CT, the proportions of hypervascular tumors during the early phase and hypodense tumors during the late phase were significantly lower among well-differentiated HCCs than among moderately and poorly differentiated HCCs, respectively (early phase, 51% vs 87%, p < 0.0001; late phase, 59% vs 85%, p < 0.0001).
CONCLUSION: Contrast-enhanced intraoperative ultrasound using Sonazoid is useful for estimating the histologic grade of HCC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21606294     DOI: 10.2214/AJR.10.4310

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  17 in total

1.  The essence of the Japan Radiological Society/Japanese College of Radiology Imaging Guideline.

Authors:  Yasuyuki Yamashita; Sadayuki Murayama; Masahiro Okada; Yoshiyuki Watanabe; Masako Kataoka; Yasushi Kaji; Keiko Imamura; Yasuo Takehara; Hiromitsu Hayashi; Kazuko Ohno; Kazuo Awai; Toshinori Hirai; Kazuyuki Kojima; Shuji Sakai; Naofumi Matsunaga; Takamichi Murakami; Kengo Yoshimitsu; Toshifumi Gabata; Kenji Matsuzaki; Eriko Tohno; Yasuhiro Kawahara; Takeo Nakayama; Shuichi Monzawa; Satoru Takahashi
Journal:  Jpn J Radiol       Date:  2016-01       Impact factor: 2.374

2.  Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy.

Authors:  Ai Amioka; Norio Masumoto; Noriko Gouda; Keiko Kajitani; Hideo Shigematsu; Akiko Emi; Takayuki Kadoya; Morihito Okada
Journal:  Jpn J Clin Oncol       Date:  2016-02-03       Impact factor: 3.019

Review 3.  Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma.

Authors:  Norihide Yoneda; Osamu Matsui; Satoshi Kobayashi; Azusa Kitao; Kazuto Kozaka; Dai Inoue; Kotaro Yoshida; Tetsuya Minami; Wataru Koda; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2019-02-02       Impact factor: 2.374

Review 4.  New paradigm for management of hepatocellular carcinoma by imaging.

Authors:  Ijin Joo; Byung Ihn Choi
Journal:  Liver Cancer       Date:  2012-09       Impact factor: 11.740

5.  Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: the utility of conventional MR imaging.

Authors:  Chen-Te Chou; Jung-Mao Chou; Ting-An Chang; Shiu-Feng Huang; Chia-Bang Chen; Yao-Li Chen; Ran-Chou Chen
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

6.  Early hemodynamics of hepatocellular carcinoma using contrast-enhanced ultrasound with Sonazoid: focus on the pure arterial and early portal phases.

Authors:  Akiko Saito; Masakazu Yamamoto; Satoshi Katagiri; Shingo Yamashita; Masayuki Nakano; Toshio Morizane
Journal:  Glob Health Med       Date:  2020-10-31

Review 7.  Hepatocellular Carcinoma: Current Imaging Modalities for Diagnosis and Prognosis.

Authors:  Maxime Ronot; Yvonne Purcell; Valérie Vilgrain
Journal:  Dig Dis Sci       Date:  2019-04       Impact factor: 3.199

Review 8.  Emerging contrast-enhanced ultrasound applications in children.

Authors:  Ryne A Didier; David M Biko; Misun Hwang; Sunil Unnikrishnan; Magdalena M Woźniak; Gibran T Yusuf; Anush Sridharan
Journal:  Pediatr Radiol       Date:  2021-04-01

Review 9.  Clinical implications of basic research in hepatocellular carcinoma.

Authors:  Renumathy Dhanasekaran; Sudhakar K Venkatesh; Michael S Torbenson; Lewis R Roberts
Journal:  J Hepatol       Date:  2015-10-09       Impact factor: 25.083

Review 10.  Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience.

Authors:  Hitoshi Maruyama; Tadashi Sekimoto; Osamu Yokosuka
Journal:  J Gastroenterol       Date:  2015-12-22       Impact factor: 6.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.